Overview


According to FutureWise analysis the market for drug discovery in 2023 is US$ 20.6 billion, and is expected to reach US$ 63.46 billion by 2031 at a CAGR of 15.1%.

Drug discovery is the process of identifying and developing new medications to treat or prevent diseases. It involves the identification of potential drug targets, the development of compounds that can interact with those targets, and the evaluation of those compounds to determine their effectiveness and safety. Drug discovery is a multi-disciplinary field that involves the expertise of scientists from various disciplines such as chemistry, biology, pharmacology, and medicine, among others. The ultimate goal of drug discovery is to identify new medications that can improve the quality of life and health outcomes for patients.

The process of drug discovery typically begins with basic research to identify potential drug targets, such as specific proteins or enzymes involved in disease processes. Once a target has been identified, researchers will screen large libraries of compounds to identify molecules that can interact with the target in a desired way.  The identified compounds are then subjected to a series of tests to assess their safety and efficacy, including tests for toxicity, pharmacokinetics, and effectiveness in animal models of disease. Promising compounds are then optimized through chemical modifications to improve their potency, selectivity, and safety.  The final stage of drug discovery involves clinical trials, where the safety and efficacy of the drug candidate are tested in human subjects. These trials are typically conducted in three phases, with increasing numbers of participants and more rigorous testing at each stage.

FutureWise Market Research has published a report that provides an insightful analysis of Drug Discovery Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

By the end of the forecast period FutureWise research analysts projects that Drug Discovery Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Laboratory Corporation of America Holdings
  • Albany Molecular Research Inc.
  • Charles River Laboratories International Inc.
  • Evotec SE
  • Eurofins Scientific
  • WuXi AppTec
  • GenScript Biotech Corporation
  • Thermo Fisher Scientific Inc.
  • Pharmaceutical Product Development LLC
  • Syngene International Ltd.
  • Selvita S.A.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Drug Discovery Market:

In October 2022, Verge Genomics, a biotechnology firm in the clinical stages, has announced the beginning of the dosing for its Phase 1 clinical trial of VRG50635. Verge Genomics is a pioneer in fusing artificial intelligence (Al) with human data to revolutionise medication discovery.

The drug discovery market is a complex and rapidly evolving space, influenced by a wide range of factors that impact drug development and market dynamics. One of the major factor is the pace of technological advances, which have revolutionized the drug discovery process in recent years. Advances in high-throughput screening, next-generation sequencing, and artificial intelligence have greatly improved the speed and efficiency of identifying potential drug candidates, enabling researchers to screen large numbers of compounds in a relatively short amount of time. This has helped to reduce the time and cost required to bring a drug to market, which is crucial for companies looking to stay competitive.

However, regulations governing the safety and efficacy of drugs are becoming increasingly stringent, which can increase the cost and time required for drug development and approval. Regulatory bodies such as the EMA, FDA and other national regulatory authorities play a critical role in shaping the drug discovery landscape, and companies must adhere to rigorous standards to ensure the safety and effectiveness of their drugs, which can hinder the market expansion. Furthermore, the demand for drugs in specific areas can change rapidly, depending on factors such as changes in disease prevalence, public health concerns, and emerging technologies. For example, the COVID-19 pandemic has driven demand for vaccines and treatments for the virus, leading to a surge in investment in this area. These are the factors which are expected to boost the market revenue in the forecast period.

By Process

  • Target Selection
  • Target Validation
  • Hit-To-Lead Identification
  • Lead Optimization
  • Candidate Validation

By Type

  • Medicinal Chemistry Services
  • Biology Services
  • Drug Metabolism and Pharmacokinetics

By Drug

  • Small Molecule Drugs
  • Biologic Drugs

By Therapeutic Area

  • Oncology
  • Central Nervous Systems
  • Cardiovascular
  • Infectious Disease
  • Metabolic Disorders
  •  Others    

By Region

  • North America
  •  Europe
  •  Asia-Pacific
  • Latin America
  •  Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Pharmaceutical and biologic R&D spending is heavily concentrated in North America. A rise in investments made by drug development companies, substantial grants provided by the United States government, a firm foothold held by major drug development companies, a well-developed healthcare infrastructure, and an increase in chronic diseases are among the factors that have contributed to the expansion of this region. For instance, In 2022, approximately 1,918,030 new cases of cancer and 609,360 deaths from the disease were reported in the United States. Due to the region's high cancer prevalence, it is anticipated that drug discovery will drive market expansion. In addition, the drug discovery market in this region is anticipated to be driven by the rise in technological advances in drug discovery in the U.S. Additionally, based on drug type; biologics and small molecule drugs hold a market share of 68.2% and 31.8% respectively in 2022 in global market.

  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global Drug Discovery Market By Process, By Type, By Drug, By Therapeutic Area and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Drug Discovery Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Drug Discovery Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Drug Discovery Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Drug Discovery Market, By Process Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)
    •   1. Target Selection
        2. Target Validation
        3. Hit-To-Lead Identification
        4. Lead Optimization
        5 . Candidate Validation

  • 8.   Drug Discovery Market, By Type Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)
    •   1. Medicinal Chemistry Services
        2. Biology Services
        3. Drug Metabolism and Pharmacokinetics

  • 9.   Drug Discovery Market, By Drug Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)
    •   1. Small Molecule Drugs
        2. Biologic Drugs

  • 10.   Drug Discovery Market, By Therapeutic Area Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)
    •   1. Oncology
           2. Central Nervous Systems
        3. Cardiovascular
        4. Infectious Disease
        5. Metabolic Disorders
        6. Others

  • 11.   North America Drug Discovery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Drug Discovery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Drug Discovery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Drug Discovery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Laboratory Corporation of America Holdings
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Albany Molecular Research Inc.
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Charles River Laboratories International Inc.
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Evotec SE
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Eurofins Scientific
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. WuXi AppTec
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. GenScript Biotech Corporation
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Thermo Fischer Scientific
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Pharmaceutical Product Development LLC
         9.1. Company Overview (HQ, Business Segments, Employee Strength)
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Syngene International Ltd.
         10.1. Company Overview (HQ, Business Segments, Employee Strength)
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Selvita S.A.
         11.1. Company Overview (HQ, Business Segments, Employee Strength)
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients